Management of Rheumatoid Arthritis with Individualized Homeopathy: A Prospective, Non-Randomized, Single-Group Interventional Study.

What was studied

This study tested individualized homeopathy in people with rheumatoid arthritis. It was a multi-center study. All patients were in one group. There was no random assignment. It enrolled 134 patients. Disease activity was tracked with the DAS28 score every 3 months for 12 months. The team also tracked joint counts, pain and disability.

What they found

Of 134 people, 74 completed the 12-month follow-up. Disease activity scores improved significantly. So did ACR20 measures. The DAS28 score fell by 1.26 points at 9 months. It fell by 1.31 points at 12 months. Common prescriptions were Rhus toxicodendron, Pulsatilla and Phosphorus.

What it means for patients

The authors say outcomes were positive over 12 months without disease-modifying drugs. They say the findings suggest a potential role in integrative care. They say controlled trials are warranted.

Why it is not certain yet

There was no comparison group. Only 74 of 134 people completed follow-up for the main analysis. The abstract says clinical evidence on homeopathy is limited. The authors say controlled trials are needed.

Source

Management of Rheumatoid Arthritis with Individualized Homeopathy: A Prospective, Non-Randomized, Single-Group Interventional Study.

We restate facts from the source record in our own words. The original wording belongs to its publisher.